Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Lupin Limited ( (IN:LUPIN) ) just unveiled an update.
Lupin Digital Health has launched a comprehensive Post-Procedure Home-Based Care Guide in collaboration with the American College of Cardiology. This initiative, announced at the India Live conference, aims to enhance patient recovery and well-being after cardiac procedures by providing structured guidance and resources for managing recovery at home. The guides, co-authored by leading cardiologists, cover various cardiac conditions and emphasize the importance of patient-centric care, aiming to reduce hospital readmissions and improve overall patient outcomes.
More about Lupin Limited
Lupin Limited operates in the pharmaceutical industry, focusing on evidence-based digital therapeutics. The company is known for its innovative healthcare solutions and collaborations with global health organizations, aiming to improve patient outcomes through digital health platforms.
YTD Price Performance: -10.54%
Average Trading Volume: 21,489
Current Market Cap: 951.8B INR
For a thorough assessment of LUPIN stock, go to TipRanks’ Stock Analysis page.